Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 1998, p. 1294-1299, Vol. 36, No. 5
Mycology Reference Laboratory,
Received 8 September 1997/Returned for modification 4 December
1997/Accepted 12 February 1998
We have developed a PCR-based method for the subspecific
discrimination of Aspergillus fumigatus types by using two
primers designed to amplify the intergenic spacer regions between
ribosomal DNA transcription units. The method permitted the
reproducible discrimination of 11 distinct DNA types among a total of
119 isolates of A. fumigatus collected from patients and
from the environment of a bone marrow transplantation (BMT) unit over a
three-year period. Ten DNA types of A. fumigatus were
isolated from patients in the BMT unit; eight of these types were also
found in the hospital environment, and six of these were present in the
unit itself. Thirteen BMT patients developed infection with one of
three DNA types some months after these had first been found in the
environment of the unit. In other instances, the same DNA types of
A. fumigatus were isolated from BMT patients that were
later recovered from the environment of the unit. Several DNA types of
A. fumigatus were found in the hospital environment over an
18-month period. Molecular typing of multiple isolates of A. fumigatus, obtained from postmortem tissue samples, showed that
one patient was infected with a single DNA type, but two others had up
to three different DNA types. Our findings suggest that A. fumigatus infection in BMT recipients may be nosocomial in origin
and underline the need for careful environmental monitoring of units in
which high-risk patients are housed.
Aspergillus fumigatus is
a ubiquitous saprobic fungus which can cause lethal infection in
neutropenic individuals. The lung is the commonest site of human
infection, most cases being the result of inhalation of spores. It is
well recognized that nosocomial outbreaks of aspergillosis often occur
in association with hospital demolition or construction works (3,
15, 30), and it has been assumed that this is due to the release
of large numbers of spores into the air. Housing neutropenic patients
in a protective environment to prevent exposure to aspergillus spores
has reduced the incidence of aspergillosis (6, 25), but
infection can still occur if air filtration systems fail or are
inadequate (17, 24). Moreover, aspergillosis can develop if
patients are colonized before their admission to a protective
environment (23) or if they are moved to other parts of a
hospital for irradiation (13) or for insertion of catheters
(1).
The evidence incriminating different environmental sources of
aspergillus infection has always been circumstantial because only
recently have reliable molecular typing methods been developed for
tracing the spread of particular subspecific types of A. fumigatus. Among the methods that have been applied to the typing
of this organism are restriction endonuclease analysis (7, 9, 18, 29) and the detection of restriction fragments by Southern
hybridization and probing with ribosomal or other repetitive sequences
(2, 10, 11, 22, 26). The application of randomly amplified polymorphic DNA (RAPD) analysis as a genotyping method has also been
reported (2, 4, 16, 18, 19, 22, 27-29).
This report describes the development of a simple PCR-based method for
the subspecific discrimination of A. fumigatus strains by
using primers which amplify intergenic spacer regions (IGS) between
ribosomal DNA transcription units. The method was used to characterize
isolates of A. fumigatus collected from patients and from
the environment of a bone marrow transplantation (BMT) unit over a
three-year period.
Isolates.
A total of 119 isolates of A. fumigatus
were collected between March 1994 and January 1997 (Table
1).
These comprised 52 isolates from 25 patients undergoing BMT at the
Bristol Royal Hospital for Sick Children, 7 isolates from 4 patients in
other parts of the hospital, 19 isolates from the environment of the BMT unit, and 41 isolates from other parts of the hospital. Isolates were confirmed as A. fumigatus on the basis of their
macroscopic and microscopic characteristics in culture. Isolates were
stored on slopes of Oxoid Sabouraud dextrose agar (Unipath Ltd.,
Basingstoke, England) at
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Molecular Epidemiological Study of
Aspergillus fumigatus in a Bone Marrow Transplantation Unit
by PCR Amplification of Ribosomal Intergenic Spacer
Sequences
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
20°C and in vials of sterile water at room
temperature.
TABLE 1.
DNA types of 119 clinical and environmental
A. fumigatus isolatesa
Hospital setting. The BMT unit, which was opened in March 1994, is supplied with filtered air under positive pressure and consists of 10 isolation rooms around a central nursing station, a changing room, a small kitchen, and a sluice room. About 60 transplants were performed per annum, between 1994 and 1996.
Environmental sampling. The environment of the BMT unit was sampled at 6-week intervals starting in March 1994. Other parts of the hospital, including two wards in which neutropenic patients were housed, were sampled at intervals of 1 to 6 months starting in April 1995. Sterile swabs, moistened in sterile distilled water, were used to collect dust from selected inanimate surfaces within each of the rooms used by the patients, the adjoining nurses' station, the kitchen, the sluice room, and the changing room. The swabs were then spread onto plates of Sabouraud dextrose agar which were incubated at 35°C and assessed for fungal growth after 48 h of incubation.
Isolation of fungal DNA.
Isolates were subcultured onto
Sabouraud dextrose agar slopes and incubated at 35°C for 3 to 5 days
to allow profuse sporulation. Aliquots of Sabouraud dextrose broth (3 ml) in 5-cm petri dishes were inoculated with spores so that there was
an even distribution over the surface of the broth. The plates were
incubated for 16 h at 37°C after which time a fine mycelial mat
was visible on the surface of the broth. The mycelial mats were removed
with sterile forceps, blotted to remove excess medium, and placed in 1.5-ml centrifuge tubes. Four glass beads (5 to 7 mm in diameter) were
added to each tube, and they were then immersed in liquid nitrogen for
30 s, removed, and allowed to thaw. Then 500 µl of lysis buffer,
pH 8.0 (200 mM Tris-HCl, 0.5 M NaCl, 10 mM EDTA, 1% [wt/vol] sodium
dodecyl sulfate), was added, and the tubes were vortexed for 30 s.
The tubes were then immersed again in liquid nitrogen for 30 s,
thawed, and revortexed for 30 s. Genomic DNA was purified from the
lysate by repeated phenol-chloroform extractions as described by
Aufauvre-Brown et al. (4). The DNA was precipitated with 0.1 volume of 5 M ammonium acetate and 1 volume of isopropanol and washed
with 70% (vol/vol) ethanol. The DNA was suspended in 40 µl of
Tris-EDTA buffer (100 mM Tris HCl, 10 mM EDTA) with a 2-µl volume of
10 mg of RNase A (Sigma Chemical Co., St. Louis, Mo.) per ml. The DNA
concentration was assessed by spectrophotometry (Genequant; Pharmacia
Biotech, St. Albans, England), and the samples were stored at
20°C
until used in PCRs.
PCR amplification. Two oligonucleotide primers targeting conserved regions near the 3' end of the large ribosomal subunit and the 5' end of the small ribosomal subunit of the ribosomal DNA gene sequences were designed (Fig. 1). The primer sequences were IGSL (5'-TAGTACGAGAGGAACCGT-3') and IGSR (5'-GCATATGACTACTGGCAG-3') and correspond to bases 120 to 137 and 2285 to 2302 of the Aspergillus nidulans sequence (EMBL accession number Z27114).
|
| |
RESULTS |
|---|
|
|
|---|
The PCR conditions used in this work were chosen on the basis of
initial tests with a range of primer, magnesium, enzyme, and dNTP
concentrations. The PCR conditions were also optimized for maximum band
intensity and reproducibility by changing the annealing temperature (45 to 55°C), the duration of individual steps (denaturation, annealing,
and synthesis), and the number of amplification cycles. The clearest,
most consistent, and most differential banding patterns were obtained
with an annealing temperature of 45°C and the reaction conditions
described in Materials and Methods. The banding patterns were
relatively resistant to changes in the amount of DNA suspension used (1 to 3 µl) and to changes in polymerase concentration (0.25 to 0.75 U/50 µl), with the same basic bands being present but with the larger
bands (
700 bp) showing slight differences in intensity (data not
shown).
The two primers, IGSL and IGSR, differentiated the 119 isolates of A. fumigatus used in this study into 11 distinct DNA types, coded A to K (Fig. 2). The DNA banding patterns, which were obtained with the optimum reaction conditions, were reproducible both on repeat PCR of the same DNA suspension and with repeated DNA extraction and PCR from different subcultures of particular isolates.
|
The sources, dates of isolation, and DNA types of the 119 isolates of A. fumigatus, collected from patients and from the environment of the BMT unit itself and from other parts of the hospital, are summarized in Table 1. Most of the isolates fell into one of five types: type H (24 isolates), type E (24 isolates), type D (21 isolates), type A (20 isolates), or type I (13 isolates). Three DNA types (types B, G, and J) were isolated on only a single occasion. Two of these isolates were from BMT patients, and the third was from a non-BMT patient. In all three cases, at least one other DNA type was recovered from the same clinical sample.
Of the eight distinct DNA types of A. fumigatus that were obtained on more than one occasion, all were isolated from both patients and the environment (Table 1). Six DNA types were recovered from BMT patients and the environment of the unit (types F, H, D, A, E, and I). All of these types were also found in the environment of other parts of the hospital. Two of the less common DNA types (types C and K), isolated from BMT patients, were also recovered from the hospital environment, although not from the environment of the BMT unit itself.
Seven of the eight DNA types of A. fumigatus that were isolated from both patients and the environment were obtained from the patients first (Table 1). The exception was type C, which was recovered from the hospital environment 3 weeks before it was first isolated from a patient on the BMT unit. Although the original isolate of A. fumigatus type D came from a non-BMT patient, this DNA type was recovered from the environment of the BMT unit 4 months before it was first isolated from a BMT patient.
The shortest time interval between the first patient and the first environmental isolation was 2 days for type E (from a non-BMT patient and the general hospital environment). The shortest interval between the first BMT patient isolation and the first isolation from the environment of the unit was 5 months (type I). The longest interval between the first isolation from a BMT patient and the first isolation from the environment of the unit was 16 months (type H). This DNA type had been isolated from seven patients on the BMT unit and one other non-BMT patient by the time it was first recovered from the hospital environment. It was subsequently isolated from three more patients and persisted in the environment for a total of 14 months. The two most persistent DNA types were types H and D, which were isolated over a 22-month period from BMT and non-BMT patients, respectively.
One patient harbored the same DNA type of A. fumigatus in two sputum samples taken 2 weeks apart (patient 26, type D) (Table 1). Three others harbored different DNA types in similar samples taken on different occasions (patient 1, types F and H; patient 22, types H and I; patient 29, types D and K). Two patients harbored two different types in the same antemortem sample (patient 7, types H and B; patient 21, types E and G).
One patient harbored 3 different DNA types of A. fumigatus in one antemortem and 15 postmortem samples (patient 18, types E, I, and K) (Table 1 and Fig. 3). Another patient harbored 3 DNA types in eight postmortem samples (patient 25, types H, I, and J) (Table 1 and Fig. 4). A third patient harbored the same DNA type in two different postmortem samples (patient 15, type A).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Invasive aspergillosis is a serious nosocomial infection, affecting 10 to 20% of neutropenic cancer patients and 0.5 to 10% of patients following BMT (8). A. fumigatus is the predominant cause of this infection, being implicated in over 80% of cases (8). Prevention of aspergillosis is difficult because of the ubiquitous nature of aspergillus spores in the environment (21). It has often been assumed that nosocomial clusters of infection occur during periods of building works in and around hospitals, because an overall increase in spore concentrations in the air leads to an increased likelihood of infection. However, tracing the sources of nosocomial aspergillus infection has been difficult, because of the lack of reliable typing methods for subspecific discrimination of the organism.
A number of DNA-based typing methods have now been developed for A. fumigatus. These include RAPD, restriction fragment length polymorphism (RFLP) detection, and Southern hybridization with various repetitive sequence-based probes. However, many of the reports that have so far been published have largely been concerned with the application of novel methods to groups of unrelated isolates which would be expected to differ irrespective of the criteria used (4, 9, 10, 18, 19, 26). Less commonly, DNA typing has been applied to the investigation of nosocomial clusters of A. fumigatus isolates to ascertain whether patients have acquired the same type and to attempt to trace the source of the infection (7, 12, 16, 20, 27). In some instances a link has been demonstrated between isolates from individual patients and potential environmental sources (7, 12, 16, 20), but in others it has not (27).
The fungal ribosomal DNA complex consists of about 100 highly conserved copies of the ribosomal gene sequences, which are tandemly repeated head to tail with spacer regions in between (5). The intergenic spacer region is the most variable part of the ribosomal DNA complex, and a number of RFLP methods have their origin here (5, 26). Previous work with Aspergillus spp., with probes and RFLPs, has indicated that the IGS region between ribosomal DNA operon repeat units is variable in length and that different copies of the complex in different isolates contain variable numbers of a 200-bp repeat unit (5).
Our results suggest that PCR amplification of the IGS region of A. fumigatus is a reproducible method for subspecific typing of this organism. We have not sequenced the amplicons to confirm that the primers are binding specifically to the intended target, but several observations suggest that this might be the case. No PCR products were observed when either one of the IGS primers was omitted; such products might have been expected if low-stringency primer binding was responsible for the IGS patterns observed. Furthermore, IGS PCR was unaffected by slight changes in amplification conditions; use of an annealing temperature of 50°C resulted in products similar to but less intense than those obtained with an annealing temperature of 45°C. We cannot be certain that some random annealing was not occurring, given that none of the IGS sequences of A. fumigatus have been determined and that some of the PCR products observed were shorter than might have been anticipated from the published details of a corresponding A. nidulans sequence (EMBL accession number Z27114). However, we found IGS PCR typing to be considerably more reproducible than were a number of RAPD and related nonspecific-primer-based analyses (data not shown).
The IGS PCR method used in this investigation permitted us to distinguish 11 distinct DNA types among a total of 119 clinical and environmental isolates of A. fumigatus. This enabled us to investigate the persistence of individual types in a hospital environment and assess their possible role in the development of nosocomial aspergillus infection. Of the eight distinct DNA types of A. fumigatus that were isolated on more than one occasion, six were recovered from the environment of the BMT unit itself as well as from other parts of the hospital (types F, H, D, A, E, and I). Two DNA types (types C and K) were recovered from the hospital environment but not from the BMT unit. A number of DNA types of A. fumigatus persisted in the hospital environment for long periods: four types (types F, D, A, and E) were found on two occasions 14 months apart, and two of these (types D and A) were recovered from the BMT unit itself on two occasions 18 months apart. Long-term persistence of particular DNA types of A. fumigatus in the hospital environment has been reported elsewhere (12).
Of the 10 DNA types of A. fumigatus that were isolated from patients on the BMT unit, 8 were also present in the hospital environment, and 6 of these were found in the unit itself. In most instances, each new DNA type was isolated from one or more patients before it was recovered from the environment for the first time. The long intervals between environmental sampling might well account for this. Moreover, environmental sampling is by its nature a rather inexact method of detecting fungal contamination, and the failure to detect A. fumigatus on a particular occasion does not mean that the organism was not present in the environment. It is notable that 13 BMT patients developed infection with type H, I, or D some months after these types had first been found in the environment of the unit. These findings suggest that some patients may have become infected with A. fumigatus from the hospital environment.
Although six different types of A. fumigatus were recovered from different locations within the environment of the BMT unit on 10 different occasions over a 25-month period, only 1 of the 19 isolates (AF106) came from one of the isolation rooms in which patients were housed. Most of the isolates were recovered from the kitchen, the sluice room, or a ventilation grill above the nursing station. However, it is possible that the spores were transmitted to the patients via staff, visitors, contaminated fomites, or air currents when doors were opened or closed.
Several of the patients studied in this investigation died with aspergillosis. Multiple isolates of A. fumigatus, obtained from postmortem tissue samples, showed that it was not unusual for more than one DNA type to be present. One patient harbored one DNA type of A. fumigatus in 14 postmortem samples and a second type in another tissue sample (patient 18, types E and I) (Table 1 and Fig. 3). Another patient was found to have three DNA types in eight postmortem samples (patient 25, types H, I, and J) (Table 1 and Fig. 4). Molecular typing of A. fumigatus isolates from patients with various forms of aspergillosis has demonstrated that many individuals are infected with a particular DNA type (9, 11). In contrast, typing of sputum isolates from cystic fibrosis patients has shown that these individuals may be colonized with many different types of A. fumigatus (29).
The results of this study show that IGS PCR typing of A. fumigatus has a potential role in the investigation of hospital outbreaks and should be of use in answering some epidemiological questions. Kostman et al. (14) have suggested that PCR ribotyping is a suitable method for typing many diverse bacterial species. The PCR ribotyping method described in this paper may also be applicable to the strain differentiation of a range of fungal species.
Our results confirm and extend those of previous molecular typing studies which demonstrated possible links between the isolates of A. fumigatus recovered from hospitalized patients with aspergillosis and potential environmental sources within the hospital (7, 12, 16, 20). We have shown that some BMT recipients became infected with particular DNA types of A. fumigatus some months after these types had first been detected in the environment of the unit in which the patients had been housed following transplantation. These findings, which suggest that A. fumigatus infection in BMT recipients may be nosocomial in origin, highlight the need for careful environmental monitoring in hospital units in which high-risk patients are housed.
| |
ACKNOWLEDGMENT |
|---|
This study was supported by a grant from the Special Trustees for the United Bristol Hospitals.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Mycology Reference Laboratory, Public Health Laboratory, Kingsdown, Bristol BS2 8EL, United Kingdom. Phone: (44) 117-928-5030. Fax: (44) 117-922-6611. E-mail: D.W.Warnock{at}PHLSBristol.btinternet.com.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Allo, M. D., J. Miller, T. Townsend, and C. Tan. 1987. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N. Engl. J. Med. 317:1105-1108[Abstract]. |
| 2. | Anderson, M. J., K. Gull, and D. W. Denning. 1996. Molecular typing by random amplification of polymorphic DNA and M13 Southern hybridization of related paired isolates of Aspergillus fumigatus. J. Clin. Microbiol. 34:87-93[Abstract]. |
| 3. | Arnow, P. M., R. L. Andersen, P. D. Mainous, and E. J. Smith. 1978. Pulmonary aspergillosis during hospital renovation. Am. Rev. Respir. Dis. 118:49-53[Medline]. |
| 4. | Aufauvre-Brown, A., J. Cohen, and D. W. Holden. 1992. Use of randomly amplified polymorphic DNA markers to distinguish isolates of Aspergillus fumigatus. J. Clin. Microbiol. 31:2991-2993. |
| 5. | Bainbridge, B. W. 1994. Modern approaches to the taxonomy of Aspergillus, p. 229-301. In K. A. Powell, A. Renwick, and J. F. Peberdy (ed.), The genus Aspergillus. Plenum Press, New York, N.Y. |
| 6. | Barnes, R. A., and T. R. Rogers. 1989. Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. J. Hosp. Infect. 14:89-94[Medline]. |
| 7. | Birch, M., N. Nolard, G. S. Shankland, and D. W. Denning. 1995. DNA typing of epidemiologically-related isolates of Aspergillus fumigatus. Epidemiol. Infect. 114:161-168[Medline]. |
| 8. | Denning, D. W. 1994. Invasive aspergillosis in immunocompromised patients. Curr. Opin. Infect. Dis. 7:456-462. |
| 9. | Denning, D. W., K. V. Clemons, L. H. Hanson, and D. A. Stevens. 1990. Restriction endonuclease analysis of total cellular DNA of Aspergillus fumigatus isolates of geographically and epidemiologically diverse origin. J. Infect. Dis. 162:1151-1158[Medline]. |
| 10. |
Girardin, H.,
J. P. Latge,
T. Srikantha,
B. Morrow, and D. R. Soll.
1993.
Development of DNA probes for fingerprinting Aspergillus fumigatus.
J. Clin. Microbiol.
31:1547-1554 |
| 11. | Girardin, H., J. Sarfati, H. Kobayashi, J. P. Bouchara, and J. P. Latge. 1994. Use of DNA moderately repetitive sequence to type Aspergillus fumigatus isolates from aspergilloma patients. J. Infect. Dis. 169:683-685[Medline]. |
| 12. |
Girardin, H.,
J. Sarfati,
F. Traore,
J. Dupouy Camet,
F. Derouin, and J. P. Latge.
1994.
Molecular epidemiology of nosocomial invasive aspergillosis.
J. Clin. Microbiol.
32:684-690 |
| 13. | Hopkins, C. C., D. J. Weber, and R. H. Rubin. 1989. Invasive aspergillus infection: possible non-ward common source within the hospital environment. J. Hosp. Infect. 13:19-25[Medline]. |
| 14. | Kostman, J. R., M. B. Alden, M. Mair, T. D. Edlind, J. J. LiPuma, and T. L. Stull. 1995. A universal approach to bacterial molecular epidemiology by polymerase chain reaction ribotyping. J. Infect. Dis. 171:204-208[Medline]. |
| 15. | Krasinski, K., R. S. Holzman, B. Hanna, M. A. Greco, M. Graff, and M. Bhogal. 1985. Nosocomial fungal infection during hospital renovation. Infect. Control 6:278-282[Medline]. |
| 16. | Leenders, A., A. van Belkum, S. Janssen, S. de Marie, J. Kluytmans, J. Wielenga, B. Lowenberg, and H. Verbrugh. 1996. Molecular epidemiology of apparent outbreak of invasive aspergillosis in a hematology ward. J. Clin. Microbiol. 34:345-351[Abstract]. |
| 17. |
Lentino, J. R.,
M. A. Rosenkranz,
J. A. Michaels,
V. P. Kurup,
H. D. Rose, and M. W. Rytel.
1982.
Nosocomial aspergillosis. A retrospective review of airborne disease secondary to road construction and contaminated air conditioners.
Am. J. Epidemiol.
116:430-437 |
| 18. | Lin, D., P. F. Lehmann, B. H. Hamory, A. A. Padhye, E. Durry, R. W. Pinner, and B. A. Lasker. 1995. Comparison of three typing methods for clinical and environmental isolates of Aspergillus fumigatus. J. Clin. Microbiol. 33:1596-1601[Abstract]. |
| 19. |
Loudon, K. W.,
J. P. Burnie,
A. P. Coke, and R. C. Matthews.
1993.
Application of polymerase chain reaction to fingerprinting Aspergillus fumigatus by random amplification of polymorphic DNA.
J. Clin. Microbiol.
31:1117-1121 |
| 20. | Loudon, K. W., A. P. Coke, J. P. Burnie, G. S. Lucas, and J. A. Liu Yin. 1994. Invasive aspergillosis: clusters and sources? J. Med. Vet. Mycol. 32:217-224[Medline]. |
| 21. | Nolard, N., M. Detandt, and H. Beguin. 1988. Ecology of Aspergillus species in the human environment, p. 35-41. In H. Vanden Bossche, D. W. R. Mackenzie, and G. Cauwenbergh (ed.), Aspergillus and aspergillosis. Plenum Publishing, New York, N.Y. |
| 22. | Rinyu, E., J. Varga, and L. Ferenczy. 1995. Phenotypic and genotypic analysis of variability in Aspergillus fumigatus. J. Clin. Microbiol. 33:2567-2575[Abstract]. |
| 23. | Robertson, M. J., and R. A. Larsen. 1988. Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy. Am. J. Med. 84:233-239[Medline]. |
| 24. | Ruutu, P., V. Valtonen, L. Tiitanen, E. Elonen, L. Volin, P. Veijalainen, and T. Ruutu. 1987. An outbreak of invasive aspergillosis in a haematologic unit. Scand. J. Infect. Dis. 19:347-351[Medline]. |
| 25. | Sherertz, R. J., A. Belani, B. S. Kramer, G. J. Elfenbein, R. S. Weiner, M. L. Sullivan, R. G. Thomas, and G. P. Samsa. 1987. Impact of air filtration on nosocomial aspergillus infections. Unique risk of bone marrow transplant recipients. Am. J. Med. 83:709-718[Medline]. |
| 26. | Spreadbury, C. L., B. W. Bainbridge, and J. Cohen. 1990. Restriction fragment length polymorphisms in isolates of Aspergillus fumigatus probed with part of the intergenic spacer region from the ribosomal RNA gene complex of Aspergillus nidulans. J. Gen. Microbiol. 136:1991-1994[Medline]. |
| 27. | Tang, C. M., J. Cohen, A. J. Rees, and D. W. Holden. 1994. Molecular epidemiological study of invasive pulmonary aspergillosis in a renal transplantation unit. Eur. J. Clin. Microbiol. Infect. Dis. 13:318-321[Medline]. |
| 28. |
van Belkum, A.,
W. G. V. Quint,
B. de Pauw,
W. J. G. Melchers, and J. F. Meis.
1993.
Typing of Aspergillus species and Aspergillus fumigatus isolates by interrepeat polymerase chain reaction.
J. Clin. Microbiol.
31:2502-2505 |
| 29. | Verweij, P. E., J. F. G. M. Meis, J. Sarfati, J. A. A. Hoogkamp-Korstanje, J. P. Latge, and W. J. G. Melchers. 1996. Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis. J. Clin. Microbiol. 34:2595-2597[Abstract]. |
| 30. | Weems, J. J., B. J. Davis, O. C. Tablan, L. Kaufman, and W. J. Martone. 1987. Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with haematologic malignancy. Infect. Control Hosp. Epidemiol. 8:71-75. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|